Simplex Trading
SMMT icon

Simplex Trading’s Summit Therapeutics SMMT Stock Holding History

Simplex Trading’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Sell
78,800
-26,000
-25% -$420K ﹤0.01% 2085
2025
Q4 		$1.83M Sell
104,800
-35,500
-25% -$668K ﹤0.01% 2049
2025
Q3 		$2.9M Sell
140,300
-95,400
-40% -$2.31M ﹤0.01% 1959
2025
Q2 		$5.01M Buy
235,700
+73,600
+45% +$1.68M ﹤0.01% 1336
2025
Q1 		$3.13M Sell
162,100
-60,200
-27% -$1.21M ﹤0.01% 1624
2024
Q4 		$3.97M Sell
222,300
-32,100
-13% -$622K ﹤0.01% 1646
2024
Q3 		$5.57M Buy
254,400
+241,100
+1,813% +$3.37M ﹤0.01% 1415
2024
Q2 		$103K Buy
13,300
+5,800
+77% +$31.3K ﹤0.01% 5343
2024
Q1 		$31K Sell
7,500
-2,500
-25% -$9.94K ﹤0.01% 6730
2023
Q4 		$26K Sell
10,000
-3,500
-26% -$7.2K ﹤0.01% 6712
2023
Q3 		$25K Sell
13,500
-7,400
-35% -$14.1K ﹤0.01% 6438
2023
Q2 		$52K Sell
20,900
-16,600
-44% -$30.3K ﹤0.01% 5811
2023
Q1 		$65K Sell
37,500
-2,700
-7% -$7.36K ﹤0.01% 5634
2022
Q4 		$170K Buy
+40,200
New +$73.1K ﹤0.01% 4425
2022
Q1 		– Sell
-2,300
Closed -$6K – 11323
2021
Q4 		$6K Buy
+2,300
New +$11.1K ﹤0.01% 9435
2018
Q4 		– Sell
-233
Closed -$51K – 7748
2018
Q3 		$51K Buy
233
+47
+25% +$108 ﹤0.01% 5150
2018
Q2 		$45K Buy
+186
New +$2.38K ﹤0.01% 5174

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Simplex Trading's SMMT Position: Q1 2026 in Review

Simplex Trading opened a new position in Summit Therapeutics (SMMT) in Q1 2026: 8,410 shares worth $159K. The stake represents ﹤0.01% of the portfolio and ranks #4572 among its holdings. This is a return to the name: Simplex Trading previously reported a position in SMMT as recently as Q2 2024.

Simplex Trading first reported a position in SMMT in Q2 2018 and has held it in 11 quarters since. The position peaked at $894K in Q2 2024. 222 funds tracked by Wall St. Rank hold SMMT as of Q1 2026.

  • Simplex Trading held 8,410 shares of Summit Therapeutics worth $159K as of Q1 2026.
  • Summit Therapeutics was a new Simplex Trading position in Q1 2026.
  • Summit Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4572 holding.
  • Simplex Trading first reported a position in Summit Therapeutics in Q2 2018 and has held it in 11 quarters since.
  • Simplex Trading's Summit Therapeutics position peaked at $894K in Q2 2024.
  • 222 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.